Global Immune Thrombocytopenic Purpura Therapeutics Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3495266
- 89 Pages
- February 2020
- Healthcare
The global Immune Thrombocytopenic Purpura Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Immune Thrombocytopenic Purpura Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Eltrombopag Olamine
Fostamatinib Disodium
GL-2045
Avatrombopag
BI-655064
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Amgen Inc.
Baxalta Incorporated
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eisai
Hansa Medical AB
Immunomedics, Inc.
Intas Pharmaceuticals Ltd.
Jiangsu Hengrui Medicine Co., Ltd.
Merck & Co., Inc.
Momenta Pharmaceuticals, Inc.
Novartis AG
Pfizer Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Immune Thrombocytopenic Purpura Therapeutics Industry
Figure Immune Thrombocytopenic Purpura Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Immune Thrombocytopenic Purpura Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Immune Thrombocytopenic Purpura Therapeutics
1.2.2 Downstream
Table Application Segment of Immune Thrombocytopenic Purpura Therapeutics
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Immune Thrombocytopenic Purpura Therapeutics Market by Type
3.1 By Type
3.1.1 Eltrombopag Olamine
Table Major Company List of Eltrombopag Olamine
3.1.2 Fostamatinib Disodium
Table Major Company List of Fostamatinib Disodium
3.1.3 GL-2045
Table Major Company List of GL-2045
3.1.4 Avatrombopag
Table Major Company List of Avatrombopag
3.1.5 BI-655064
Table Major Company List of BI-655064
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Type, in USD Million
Figure Global Immune Thrombocytopenic Purpura Therapeutics Market Growth 2015-2019, by Type, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Type, in Volume
Figure Global Immune Thrombocytopenic Purpura Therapeutics Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Type, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Amgen Inc. (Company Profile, Sales Data etc.)
4.1.1 Amgen Inc. Profile
Table Amgen Inc. Overview List
4.1.2 Amgen Inc. Products & Services
4.1.3 Amgen Inc. Business Operation Conditions
Table Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Baxalta Incorporated (Company Profile, Sales Data etc.)
4.2.1 Baxalta Incorporated Profile
Table Baxalta Incorporated Overview List
4.2.2 Baxalta Incorporated Products & Services
4.2.3 Baxalta Incorporated Business Operation Conditions
Table Business Operation of Baxalta Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
4.3.1 Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Overview List
4.3.2 Boehringer Ingelheim GmbH Products & Services
4.3.3 Boehringer Ingelheim GmbH Business Operation Conditions
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
4.4.1 Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Overview List
4.4.2 Bristol-Myers Squibb Company Products & Services
4.4.3 Bristol-Myers Squibb Company Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Eisai (Company Profile, Sales Data etc.)
4.5.1 Eisai Profile
Table Eisai Overview List
4.5.2 Eisai Products & Services
4.5.3 Eisai Business Operation Conditions
Table Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Hansa Medical AB (Company Profile, Sales Data etc.)
4.6.1 Hansa Medical AB Profile
Table Hansa Medical AB Overview List
4.6.2 Hansa Medical AB Products & Services
4.6.3 Hansa Medical AB Business Operation Conditions
Table Business Operation of Hansa Medical AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Immunomedics, Inc. (Company Profile, Sales Data etc.)
4.7.1 Immunomedics, Inc. Profile
Table Immunomedics, Inc. Overview List
4.7.2 Immunomedics, Inc. Products & Services
4.7.3 Immunomedics, Inc. Business Operation Conditions
Table Business Operation of Immunomedics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Intas Pharmaceuticals Ltd. (Company Profile, Sales Data etc.)
4.8.1 Intas Pharmaceuticals Ltd. Profile
Table Intas Pharmaceuticals Ltd. Overview List
4.8.2 Intas Pharmaceuticals Ltd. Products & Services
4.8.3 Intas Pharmaceuticals Ltd. Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Jiangsu Hengrui Medicine Co., Ltd. (Company Profile, Sales Data etc.)
4.9.1 Jiangsu Hengrui Medicine Co., Ltd. Profile
Table Jiangsu Hengrui Medicine Co., Ltd. Overview List
4.9.2 Jiangsu Hengrui Medicine Co., Ltd. Products & Services
4.9.3 Jiangsu Hengrui Medicine Co., Ltd. Business Operation Conditions
Table Business Operation of Jiangsu Hengrui Medicine Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Merck & Co., Inc. (Company Profile, Sales Data etc.)
4.10.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
4.10.2 Merck & Co., Inc. Products & Services
4.10.3 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Momenta Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.11.1 Momenta Pharmaceuticals, Inc. Profile
Table Momenta Pharmaceuticals, Inc. Overview List
4.11.2 Momenta Pharmaceuticals, Inc. Products & Services
4.11.3 Momenta Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Momenta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Novartis AG (Company Profile, Sales Data etc.)
4.12.1 Novartis AG Profile
Table Novartis AG Overview List
4.12.2 Novartis AG Products & Services
4.12.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Cost, Gross Margin)
4.13 Pfizer Inc. (Company Profile, Sales Data etc.)
4.13.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.13.2 Pfizer Inc. Products & Services
4.13.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Revenue 2015-2019, by Company, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Immune Thrombocytopenic Purpura Therapeutics Sales Revenue Share in 2019, by Company, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Volume 2015-2019, by Company, in Volume
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Immune Thrombocytopenic Purpura Therapeutics Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Immune Thrombocytopenic Purpura Therapeutics Market Concentration, in 2019
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Market Market Concentration, in 2019
Figure Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics MMarket Concentration, in 2019
Figure South America Immune Thrombocytopenic Purpura Therapeutics Market Concentration, in 2019
Figure Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Immune Thrombocytopenic Purpura Therapeutics Demand in Hospital, 2015-2019, in USD Million
Figure Immune Thrombocytopenic Purpura Therapeutics Demand in Hospital, 2015-2019, in Volume
6.1.2 Demand in Clinic
Figure Immune Thrombocytopenic Purpura Therapeutics Demand in Clinic, 2015-2019, in USD Million
Figure Immune Thrombocytopenic Purpura Therapeutics Demand in Clinic, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Immune Thrombocytopenic Purpura Therapeutics Demand in Others, 2015-2019, in USD Million
Figure Immune Thrombocytopenic Purpura Therapeutics Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Immune Thrombocytopenic Purpura Therapeutics Demand Forecast 2020-2025, by Application, in USD Million
Figure Immune Thrombocytopenic Purpura Therapeutics Market Growth 2020-2025, by Application, in USD Million
Figure Immune Thrombocytopenic Purpura Therapeutics Market Share in 2025, by Application, in USD Million
Table Immune Thrombocytopenic Purpura Therapeutics Demand Forecast 2020-2025, by Application, in Volume
Table Immune Thrombocytopenic Purpura Therapeutics Market Growth 2020-2025, by Application, in Volume
Table Immune Thrombocytopenic Purpura Therapeutics Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Immune Thrombocytopenic Purpura Therapeutics Production 2015-2019, by Region, in USD Million
Table Immune Thrombocytopenic Purpura Therapeutics Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Region, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Share 2015-2019, by Region, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Region, in Volume
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure North America Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table North America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Europe Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure South America Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table South America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Region, in USD Million
Table Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Immune Thrombocytopenic Purpura Therapeutics
Table Application Segment of Immune Thrombocytopenic Purpura Therapeutics
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2025, by Application, in USD Million
Table Major Company List of Fostamatinib Disodium
Table Major Company List of GL-2045
Table Major Company List of Avatrombopag
Table Major Company List of BI-655064
Table Major Company List of Others
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Type, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Type, in Volume
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Type, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Type, in Volume
Table Amgen Inc. Overview List
Table Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Baxalta Incorporated Overview List
Table Business Operation of Baxalta Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Overview List
Table Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hansa Medical AB Overview List
Table Business Operation of Hansa Medical AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Immunomedics, Inc. Overview List
Table Business Operation of Immunomedics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Pharmaceuticals Ltd. Overview List
Table Business Operation of Intas Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jiangsu Hengrui Medicine Co., Ltd. Overview List
Table Business Operation of Jiangsu Hengrui Medicine Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Momenta Pharmaceuticals, Inc. Overview List
Table Business Operation of Momenta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Business Operation of Novartis AG (Sales Revenue, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Revenue 2015-2019, by Company, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Volume 2015-2019, by Company, in Volume
Table Global Immune Thrombocytopenic Purpura Therapeutics Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Immune Thrombocytopenic Purpura Therapeutics Demand Forecast 2020-2025, by Application, in USD Million
Table Immune Thrombocytopenic Purpura Therapeutics Demand Forecast 2020-2025, by Application, in Volume
Table Immune Thrombocytopenic Purpura Therapeutics Market Growth 2020-2025, by Application, in Volume
Table Immune Thrombocytopenic Purpura Therapeutics Market Share in 2025, by Application, in Volume
Table Immune Thrombocytopenic Purpura Therapeutics Production 2015-2019, by Region, in USD Million
Table Immune Thrombocytopenic Purpura Therapeutics Production 2015-2019, by Region, in Volume
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Region, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Share 2015-2019, by Region, in USD Million
Table Global Immune Thrombocytopenic Purpura Therapeutics Market 2015-2019, by Region, in Volume
Table Global Immune Thrombocytopenic Purpura Therapeutics Market Share 2015-2019, by Region, in Volume
Table North America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table North America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
Table Europe Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Europe Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
Table South America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table South America Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Market Size 2015-2019, by Country, in Volume
Table Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Region, in USD Million
Table Immune Thrombocytopenic Purpura Therapeutics Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
